世界の子宮頸がん分子診断市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Cervical Cancer Molecular Diagnostics Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-3997 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、106ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査レポートでは、子宮頸がん分子診断の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（PCR、FISH、DNAシーケンシング、ジーンチップ）、用途別市場規模（臨床診断、薬物スクリーニング、研究所）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・子宮頸がん分子診断の市場動向 ・企業の競争状況、市場シェア ・子宮頸がん分子診断の種類別市場規模と予測2016-2027（PCR、FISH、DNAシーケンシング、ジーンチップ） ・子宮頸がん分子診断の用途別市場規模と予測2016-2027（臨床診断、薬物スクリーニング、研究所） ・子宮頸がん分子診断の北米市場規模2016-2027（アメリカ、カナダ） ・子宮頸がん分子診断の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・子宮頸がん分子診断のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・子宮頸がん分子診断の中南米市場規模2016-2027（メキシコ、ブラジル） ・子宮頸がん分子診断の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Hologic、Foundationmedicine、Roche、Hybribio、Daangene、Liferiver、KHB、Tellgen、YanengBIO、Gpmedical、Amoydx、Amplly） ・結論

A molecular approach for diagnosing cervical cancer

Market Analysis and Insights: Global Cervical Cancer Molecular Diagnostics Market
The global Cervical Cancer Molecular Diagnostics market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Cervical Cancer Molecular Diagnostics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Cervical Cancer Molecular Diagnostics market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Cervical Cancer Molecular Diagnostics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Cervical Cancer Molecular Diagnostics market.

Global Cervical Cancer Molecular Diagnostics Scope and Market Size
Cervical Cancer Molecular Diagnostics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Cervical Cancer Molecular Diagnostics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
PCR
FISH
DNA Sequencing
Gene Chip

Segment by Application
Clinical Diagnosis
Drug Screening
Research

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Hologic
Foundationmedicine
Roche
Hybribio
Daangene
Liferiver
KHB
Tellgen
YanengBIO
Gpmedical
Amoydx
Amplly

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cervical Cancer Molecular Diagnostics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 PCR
1.2.3 FISH
1.2.4 DNA Sequencing
1.2.5 Gene Chip
1.3 Market by Application
1.3.1 Global Cervical Cancer Molecular Diagnostics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Clinical Diagnosis
1.3.3 Drug Screening
1.3.4 Research
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Cervical Cancer Molecular Diagnostics Market Perspective (2016-2027)
2.2 Cervical Cancer Molecular Diagnostics Growth Trends by Regions
2.2.1 Cervical Cancer Molecular Diagnostics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Cervical Cancer Molecular Diagnostics Historic Market Share by Regions (2016-2021)
2.2.3 Cervical Cancer Molecular Diagnostics Forecasted Market Size by Regions (2022-2027)
2.3 Cervical Cancer Molecular Diagnostics Industry Dynamic
2.3.1 Cervical Cancer Molecular Diagnostics Market Trends
2.3.2 Cervical Cancer Molecular Diagnostics Market Drivers
2.3.3 Cervical Cancer Molecular Diagnostics Market Challenges
2.3.4 Cervical Cancer Molecular Diagnostics Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Cervical Cancer Molecular Diagnostics Players by Revenue
3.1.1 Global Top Cervical Cancer Molecular Diagnostics Players by Revenue (2016-2021)
3.1.2 Global Cervical Cancer Molecular Diagnostics Revenue Market Share by Players (2016-2021)
3.2 Global Cervical Cancer Molecular Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Cervical Cancer Molecular Diagnostics Revenue
3.4 Global Cervical Cancer Molecular Diagnostics Market Concentration Ratio
3.4.1 Global Cervical Cancer Molecular Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cervical Cancer Molecular Diagnostics Revenue in 2020
3.5 Cervical Cancer Molecular Diagnostics Key Players Head office and Area Served
3.6 Key Players Cervical Cancer Molecular Diagnostics Product Solution and Service
3.7 Date of Enter into Cervical Cancer Molecular Diagnostics Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Cervical Cancer Molecular Diagnostics Breakdown Data by Type
4.1 Global Cervical Cancer Molecular Diagnostics Historic Market Size by Type (2016-2021)
4.2 Global Cervical Cancer Molecular Diagnostics Forecasted Market Size by Type (2022-2027)

5 Cervical Cancer Molecular Diagnostics Breakdown Data by Application
5.1 Global Cervical Cancer Molecular Diagnostics Historic Market Size by Application (2016-2021)
5.2 Global Cervical Cancer Molecular Diagnostics Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Cervical Cancer Molecular Diagnostics Market Size (2016-2027)
6.2 North America Cervical Cancer Molecular Diagnostics Market Size by Type
6.2.1 North America Cervical Cancer Molecular Diagnostics Market Size by Type (2016-2021)
6.2.2 North America Cervical Cancer Molecular Diagnostics Market Size by Type (2022-2027)
6.2.3 North America Cervical Cancer Molecular Diagnostics Market Size by Type (2016-2027)
6.3 North America Cervical Cancer Molecular Diagnostics Market Size by Application
6.3.1 North America Cervical Cancer Molecular Diagnostics Market Size by Application (2016-2021)
6.3.2 North America Cervical Cancer Molecular Diagnostics Market Size by Application (2022-2027)
6.3.3 North America Cervical Cancer Molecular Diagnostics Market Size by Application (2016-2027)
6.4 North America Cervical Cancer Molecular Diagnostics Market Size by Country
6.4.1 North America Cervical Cancer Molecular Diagnostics Market Size by Country (2016-2021)
6.4.2 North America Cervical Cancer Molecular Diagnostics Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Cervical Cancer Molecular Diagnostics Market Size (2016-2027)
7.2 Europe Cervical Cancer Molecular Diagnostics Market Size by Type
7.2.1 Europe Cervical Cancer Molecular Diagnostics Market Size by Type (2016-2021)
7.2.2 Europe Cervical Cancer Molecular Diagnostics Market Size by Type (2022-2027)
7.2.3 Europe Cervical Cancer Molecular Diagnostics Market Size by Type (2016-2027)
7.3 Europe Cervical Cancer Molecular Diagnostics Market Size by Application
7.3.1 Europe Cervical Cancer Molecular Diagnostics Market Size by Application (2016-2021)
7.3.2 Europe Cervical Cancer Molecular Diagnostics Market Size by Application (2022-2027)
7.3.3 Europe Cervical Cancer Molecular Diagnostics Market Size by Application (2016-2027)
7.4 Europe Cervical Cancer Molecular Diagnostics Market Size by Country
7.4.1 Europe Cervical Cancer Molecular Diagnostics Market Size by Country (2016-2021)
7.4.2 Europe Cervical Cancer Molecular Diagnostics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Cervical Cancer Molecular Diagnostics Market Size (2016-2027)
8.2 Asia-Pacific Cervical Cancer Molecular Diagnostics Market Size by Type
8.2.1 Asia-Pacific Cervical Cancer Molecular Diagnostics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Cervical Cancer Molecular Diagnostics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Cervical Cancer Molecular Diagnostics Market Size by Type (2016-2027)
8.3 Asia-Pacific Cervical Cancer Molecular Diagnostics Market Size by Application
8.3.1 Asia-Pacific Cervical Cancer Molecular Diagnostics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Cervical Cancer Molecular Diagnostics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Cervical Cancer Molecular Diagnostics Market Size by Application (2016-2027)
8.4 Asia-Pacific Cervical Cancer Molecular Diagnostics Market Size by Region
8.4.1 Asia-Pacific Cervical Cancer Molecular Diagnostics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Cervical Cancer Molecular Diagnostics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Cervical Cancer Molecular Diagnostics Market Size (2016-2027)
9.2 Latin America Cervical Cancer Molecular Diagnostics Market Size by Type
9.2.1 Latin America Cervical Cancer Molecular Diagnostics Market Size by Type (2016-2021)
9.2.2 Latin America Cervical Cancer Molecular Diagnostics Market Size by Type (2022-2027)
9.2.3 Latin America Cervical Cancer Molecular Diagnostics Market Size by Type (2016-2027)
9.3 Latin America Cervical Cancer Molecular Diagnostics Market Size by Application
9.3.1 Latin America Cervical Cancer Molecular Diagnostics Market Size by Application (2016-2021)
9.3.2 Latin America Cervical Cancer Molecular Diagnostics Market Size by Application (2022-2027)
9.3.3 Latin America Cervical Cancer Molecular Diagnostics Market Size by Application (2016-2027)
9.4 Latin America Cervical Cancer Molecular Diagnostics Market Size by Country
9.4.1 Latin America Cervical Cancer Molecular Diagnostics Market Size by Country (2016-2021)
9.4.2 Latin America Cervical Cancer Molecular Diagnostics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Cervical Cancer Molecular Diagnostics Market Size (2016-2027)
10.2 Middle East & Africa Cervical Cancer Molecular Diagnostics Market Size by Type
10.2.1 Middle East & Africa Cervical Cancer Molecular Diagnostics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Cervical Cancer Molecular Diagnostics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Cervical Cancer Molecular Diagnostics Market Size by Type (2016-2027)
10.3 Middle East & Africa Cervical Cancer Molecular Diagnostics Market Size by Application
10.3.1 Middle East & Africa Cervical Cancer Molecular Diagnostics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Cervical Cancer Molecular Diagnostics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Cervical Cancer Molecular Diagnostics Market Size by Application (2016-2027)
10.4 Middle East & Africa Cervical Cancer Molecular Diagnostics Market Size by Country
10.4.1 Middle East & Africa Cervical Cancer Molecular Diagnostics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Cervical Cancer Molecular Diagnostics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Hologic
11.1.1 Hologic Company Details
11.1.2 Hologic Business Overview
11.1.3 Hologic Cervical Cancer Molecular Diagnostics Introduction
11.1.4 Hologic Revenue in Cervical Cancer Molecular Diagnostics Business (2016-2021)
11.1.5 Hologic Recent Development
11.2 Foundationmedicine
11.2.1 Foundationmedicine Company Details
11.2.2 Foundationmedicine Business Overview
11.2.3 Foundationmedicine Cervical Cancer Molecular Diagnostics Introduction
11.2.4 Foundationmedicine Revenue in Cervical Cancer Molecular Diagnostics Business (2016-2021)
11.2.5 Foundationmedicine Recent Development
11.3 Roche
11.3.1 Roche Company Details
11.3.2 Roche Business Overview
11.3.3 Roche Cervical Cancer Molecular Diagnostics Introduction
11.3.4 Roche Revenue in Cervical Cancer Molecular Diagnostics Business (2016-2021)
11.3.5 Roche Recent Development
11.4 Hybribio
11.4.1 Hybribio Company Details
11.4.2 Hybribio Business Overview
11.4.3 Hybribio Cervical Cancer Molecular Diagnostics Introduction
11.4.4 Hybribio Revenue in Cervical Cancer Molecular Diagnostics Business (2016-2021)
11.4.5 Hybribio Recent Development
11.5 Daangene
11.5.1 Daangene Company Details
11.5.2 Daangene Business Overview
11.5.3 Daangene Cervical Cancer Molecular Diagnostics Introduction
11.5.4 Daangene Revenue in Cervical Cancer Molecular Diagnostics Business (2016-2021)
11.5.5 Daangene Recent Development
11.6 Liferiver
11.6.1 Liferiver Company Details
11.6.2 Liferiver Business Overview
11.6.3 Liferiver Cervical Cancer Molecular Diagnostics Introduction
11.6.4 Liferiver Revenue in Cervical Cancer Molecular Diagnostics Business (2016-2021)
11.6.5 Liferiver Recent Development
11.7 KHB
11.7.1 KHB Company Details
11.7.2 KHB Business Overview
11.7.3 KHB Cervical Cancer Molecular Diagnostics Introduction
11.7.4 KHB Revenue in Cervical Cancer Molecular Diagnostics Business (2016-2021)
11.7.5 KHB Recent Development
11.8 Tellgen
11.8.1 Tellgen Company Details
11.8.2 Tellgen Business Overview
11.8.3 Tellgen Cervical Cancer Molecular Diagnostics Introduction
11.8.4 Tellgen Revenue in Cervical Cancer Molecular Diagnostics Business (2016-2021)
11.8.5 Tellgen Recent Development
11.9 YanengBIO
11.9.1 YanengBIO Company Details
11.9.2 YanengBIO Business Overview
11.9.3 YanengBIO Cervical Cancer Molecular Diagnostics Introduction
11.9.4 YanengBIO Revenue in Cervical Cancer Molecular Diagnostics Business (2016-2021)
11.9.5 YanengBIO Recent Development
11.10 Gpmedical
11.10.1 Gpmedical Company Details
11.10.2 Gpmedical Business Overview
11.10.3 Gpmedical Cervical Cancer Molecular Diagnostics Introduction
11.10.4 Gpmedical Revenue in Cervical Cancer Molecular Diagnostics Business (2016-2021)
11.10.5 Gpmedical Recent Development
11.11 Amoydx
11.11.1 Amoydx Company Details
11.11.2 Amoydx Business Overview
11.11.3 Amoydx Cervical Cancer Molecular Diagnostics Introduction
11.11.4 Amoydx Revenue in Cervical Cancer Molecular Diagnostics Business (2016-2021)
11.11.5 Amoydx Recent Development
11.12 Amplly
11.12.1 Amplly Company Details
11.12.2 Amplly Business Overview
11.12.3 Amplly Cervical Cancer Molecular Diagnostics Introduction
11.12.4 Amplly Revenue in Cervical Cancer Molecular Diagnostics Business (2016-2021)
11.12.5 Amplly Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Cervical Cancer Molecular Diagnostics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of PCR
Table 3. Key Players of FISH
Table 4. Key Players of DNA Sequencing
Table 5. Key Players of Gene Chip
Table 6. Global Cervical Cancer Molecular Diagnostics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Cervical Cancer Molecular Diagnostics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Cervical Cancer Molecular Diagnostics Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Cervical Cancer Molecular Diagnostics Market Share by Regions (2016-2021)
Table 10. Global Cervical Cancer Molecular Diagnostics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Cervical Cancer Molecular Diagnostics Market Share by Regions (2022-2027)
Table 12. Cervical Cancer Molecular Diagnostics Market Trends
Table 13. Cervical Cancer Molecular Diagnostics Market Drivers
Table 14. Cervical Cancer Molecular Diagnostics Market Challenges
Table 15. Cervical Cancer Molecular Diagnostics Market Restraints
Table 16. Global Cervical Cancer Molecular Diagnostics Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Cervical Cancer Molecular Diagnostics Market Share by Players (2016-2021)
Table 18. Global Top Cervical Cancer Molecular Diagnostics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cervical Cancer Molecular Diagnostics as of 2020)
Table 19. Ranking of Global Top Cervical Cancer Molecular Diagnostics Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Cervical Cancer Molecular Diagnostics Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Cervical Cancer Molecular Diagnostics Product Solution and Service
Table 23. Date of Enter into Cervical Cancer Molecular Diagnostics Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Cervical Cancer Molecular Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Cervical Cancer Molecular Diagnostics Revenue Market Share by Type (2016-2021)
Table 27. Global Cervical Cancer Molecular Diagnostics Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Cervical Cancer Molecular Diagnostics Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Cervical Cancer Molecular Diagnostics Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Cervical Cancer Molecular Diagnostics Revenue Market Share by Application (2016-2021)
Table 31. Global Cervical Cancer Molecular Diagnostics Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Cervical Cancer Molecular Diagnostics Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Cervical Cancer Molecular Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Cervical Cancer Molecular Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Cervical Cancer Molecular Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Cervical Cancer Molecular Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Cervical Cancer Molecular Diagnostics Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Cervical Cancer Molecular Diagnostics Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Cervical Cancer Molecular Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Cervical Cancer Molecular Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Cervical Cancer Molecular Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Cervical Cancer Molecular Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Cervical Cancer Molecular Diagnostics Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Cervical Cancer Molecular Diagnostics Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Cervical Cancer Molecular Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Cervical Cancer Molecular Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Cervical Cancer Molecular Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Cervical Cancer Molecular Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Cervical Cancer Molecular Diagnostics Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Cervical Cancer Molecular Diagnostics Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Cervical Cancer Molecular Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Cervical Cancer Molecular Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Cervical Cancer Molecular Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Cervical Cancer Molecular Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Cervical Cancer Molecular Diagnostics Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Cervical Cancer Molecular Diagnostics Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Cervical Cancer Molecular Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Cervical Cancer Molecular Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Cervical Cancer Molecular Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Cervical Cancer Molecular Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Cervical Cancer Molecular Diagnostics Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Cervical Cancer Molecular Diagnostics Market Size by Country (2022-2027) & (US$ Million)
Table 63. Hologic Company Details
Table 64. Hologic Business Overview
Table 65. Hologic Cervical Cancer Molecular Diagnostics Product
Table 66. Hologic Revenue in Cervical Cancer Molecular Diagnostics Business (2016-2021) & (US$ Million)
Table 67. Hologic Recent Development
Table 68. Foundationmedicine Company Details
Table 69. Foundationmedicine Business Overview
Table 70. Foundationmedicine Cervical Cancer Molecular Diagnostics Product
Table 71. Foundationmedicine Revenue in Cervical Cancer Molecular Diagnostics Business (2016-2021) & (US$ Million)
Table 72. Foundationmedicine Recent Development
Table 73. Roche Company Details
Table 74. Roche Business Overview
Table 75. Roche Cervical Cancer Molecular Diagnostics Product
Table 76. Roche Revenue in Cervical Cancer Molecular Diagnostics Business (2016-2021) & (US$ Million)
Table 77. Roche Recent Development
Table 78. Hybribio Company Details
Table 79. Hybribio Business Overview
Table 80. Hybribio Cervical Cancer Molecular Diagnostics Product
Table 81. Hybribio Revenue in Cervical Cancer Molecular Diagnostics Business (2016-2021) & (US$ Million)
Table 82. Hybribio Recent Development
Table 83. Daangene Company Details
Table 84. Daangene Business Overview
Table 85. Daangene Cervical Cancer Molecular Diagnostics Product
Table 86. Daangene Revenue in Cervical Cancer Molecular Diagnostics Business (2016-2021) & (US$ Million)
Table 87. Daangene Recent Development
Table 88. Liferiver Company Details
Table 89. Liferiver Business Overview
Table 90. Liferiver Cervical Cancer Molecular Diagnostics Product
Table 91. Liferiver Revenue in Cervical Cancer Molecular Diagnostics Business (2016-2021) & (US$ Million)
Table 92. Liferiver Recent Development
Table 93. KHB Company Details
Table 94. KHB Business Overview
Table 95. KHB Cervical Cancer Molecular Diagnostics Product
Table 96. KHB Revenue in Cervical Cancer Molecular Diagnostics Business (2016-2021) & (US$ Million)
Table 97. KHB Recent Development
Table 98. Tellgen Company Details
Table 99. Tellgen Business Overview
Table 100. Tellgen Revenue in Cervical Cancer Molecular Diagnostics Business (2016-2021) & (US$ Million)
Table 101. Tellgen Recent Development
Table 102. YanengBIO Company Details
Table 103. YanengBIO Business Overview
Table 104. YanengBIO Cervical Cancer Molecular Diagnostics Product
Table 105. YanengBIO Revenue in Cervical Cancer Molecular Diagnostics Business (2016-2021) & (US$ Million)
Table 106. YanengBIO Recent Development
Table 107. Gpmedical Company Details
Table 108. Gpmedical Business Overview
Table 109. Gpmedical Cervical Cancer Molecular Diagnostics Product
Table 110. Gpmedical Revenue in Cervical Cancer Molecular Diagnostics Business (2016-2021) & (US$ Million)
Table 111. Gpmedical Recent Development
Table 112. Amoydx Company Details
Table 113. Amoydx Business Overview
Table 114. Amoydx Cervical Cancer Molecular Diagnostics Product
Table 115. Amoydx Revenue in Cervical Cancer Molecular Diagnostics Business (2016-2021) & (US$ Million)
Table 116. Amoydx Recent Development
Table 117. Amplly Company Details
Table 118. Amplly Business Overview
Table 119. Amplly Cervical Cancer Molecular Diagnostics Product
Table 120. Amplly Revenue in Cervical Cancer Molecular Diagnostics Business (2016-2021) & (US$ Million)
Table 121. Amplly Recent Development
Table 122. Research Programs/Design for This Report
Table 123. Key Data Information from Secondary Sources
Table 124. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Cervical Cancer Molecular Diagnostics Market Share by Type: 2020 VS 2027
Figure 2. PCR Features
Figure 3. FISH Features
Figure 4. DNA Sequencing Features
Figure 5. Gene Chip Features
Figure 6. Global Cervical Cancer Molecular Diagnostics Market Share by Application: 2020 VS 2027
Figure 7. Clinical Diagnosis Case Studies
Figure 8. Drug Screening Case Studies
Figure 9. Research Case Studies
Figure 10. Cervical Cancer Molecular Diagnostics Report Years Considered
Figure 11. Global Cervical Cancer Molecular Diagnostics Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Cervical Cancer Molecular Diagnostics Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Cervical Cancer Molecular Diagnostics Market Share by Regions: 2020 VS 2027
Figure 14. Global Cervical Cancer Molecular Diagnostics Market Share by Regions (2022-2027)
Figure 15. Global Cervical Cancer Molecular Diagnostics Market Share by Players in 2020
Figure 16. Global Top Cervical Cancer Molecular Diagnostics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cervical Cancer Molecular Diagnostics as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Cervical Cancer Molecular Diagnostics Revenue in 2020
Figure 18. Global Cervical Cancer Molecular Diagnostics Revenue Market Share by Type (2016-2021)
Figure 19. Global Cervical Cancer Molecular Diagnostics Revenue Market Share by Type (2022-2027)
Figure 20. North America Cervical Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Cervical Cancer Molecular Diagnostics Market Share by Type (2016-2027)
Figure 22. North America Cervical Cancer Molecular Diagnostics Market Share by Application (2016-2027)
Figure 23. North America Cervical Cancer Molecular Diagnostics Market Share by Country (2016-2027)
Figure 24. United States Cervical Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Cervical Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Cervical Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Cervical Cancer Molecular Diagnostics Market Share by Type (2016-2027)
Figure 28. Europe Cervical Cancer Molecular Diagnostics Market Share by Application (2016-2027)
Figure 29. Europe Cervical Cancer Molecular Diagnostics Market Share by Country (2016-2027)
Figure 30. Germany Cervical Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Cervical Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Cervical Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Cervical Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Cervical Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Cervical Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Cervical Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Cervical Cancer Molecular Diagnostics Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Cervical Cancer Molecular Diagnostics Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Cervical Cancer Molecular Diagnostics Market Share by Region (2016-2027)
Figure 40. China Cervical Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Cervical Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Cervical Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Cervical Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Cervical Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Cervical Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Cervical Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Cervical Cancer Molecular Diagnostics Market Share by Type (2016-2027)
Figure 48. Latin America Cervical Cancer Molecular Diagnostics Market Share by Application (2016-2027)
Figure 49. Latin America Cervical Cancer Molecular Diagnostics Market Share by Country (2016-2027)
Figure 50. Mexico Cervical Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Cervical Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Cervical Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Cervical Cancer Molecular Diagnostics Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Cervical Cancer Molecular Diagnostics Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Cervical Cancer Molecular Diagnostics Market Share by Country (2016-2027)
Figure 56. Turkey Cervical Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Cervical Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Cervical Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Hologic Revenue Growth Rate in Cervical Cancer Molecular Diagnostics Business (2016-2021)
Figure 60. Foundationmedicine Revenue Growth Rate in Cervical Cancer Molecular Diagnostics Business (2016-2021)
Figure 61. Roche Revenue Growth Rate in Cervical Cancer Molecular Diagnostics Business (2016-2021)
Figure 62. Hybribio Revenue Growth Rate in Cervical Cancer Molecular Diagnostics Business (2016-2021)
Figure 63. Daangene Revenue Growth Rate in Cervical Cancer Molecular Diagnostics Business (2016-2021)
Figure 64. Liferiver Revenue Growth Rate in Cervical Cancer Molecular Diagnostics Business (2016-2021)
Figure 65. KHB Revenue Growth Rate in Cervical Cancer Molecular Diagnostics Business (2016-2021)
Figure 66. Tellgen Revenue Growth Rate in Cervical Cancer Molecular Diagnostics Business (2016-2021)
Figure 67. YanengBIO Revenue Growth Rate in Cervical Cancer Molecular Diagnostics Business (2016-2021)
Figure 68. Gpmedical Revenue Growth Rate in Cervical Cancer Molecular Diagnostics Business (2016-2021)
Figure 69. Amoydx Revenue Growth Rate in Cervical Cancer Molecular Diagnostics Business (2016-2021)
Figure 70. Amplly Revenue Growth Rate in Cervical Cancer Molecular Diagnostics Business (2016-2021)
Figure 71. Bottom-up and Top-down Approaches for This Report
Figure 72. Data Triangulation
Figure 73. Key Executives Interviewed

---